{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T22:42:33Z","timestamp":1722811353350},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.5414\/cp203979","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T12:15:48Z","timestamp":1618575348000},"page":"557-565","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials"],"prefix":"10.5414","volume":"59","author":[{"given":"Yoon-Kyoung","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T12:43:44Z","timestamp":1628513024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=187915&doi=10.5414\/CP203979&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":0,"journal-issue":{"issue":"08","published-print":{"date-parts":[[2021]]}},"alternative-id":["203979"],"URL":"https:\/\/doi.org\/10.5414\/cp203979","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}